http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba162cbe15c586f80c8ae8cca7804eb3
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Fox |
| name | Edward A. Fox Edward A Fox |
| given-name | Edward A Edward A. |
| organization-name | Behavioral Neurogenetics Laboratory, Department of Psychological Sciences, Purdue University, West Lafayette, Indiana Brigham and Women's Hospital Boston Massachusetts From the Bing Program for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston; CareStat, Newton, MA; UCLA Medical Center, Los Angeles, CA; Greenebaum Cancer Center, University of Maryland, Baltimore, MD; Nevada Cancer Center, Las Vegas, NV; Fred Hutchinson Cancer Research Center, Seattle WA; and Karolinska University Hospital, Stockholm, Sweden From the Dana-Farber Cancer Institute, Boston, MA; MD Anderson Cancer Center, Houston, TX; Memorial Sloan-Kettering Cancer Center, New York, NY; and Novartis, Basel, Switzerland. Authors' Affiliations: Departments of 1Medical Oncology and 2Biostatistics and Computational Biology, and 3Microarray Core, Dana-Farber Cancer Institute and Harvard Medical School, Boston; 4Department of Pathology, Brigham and Women's Hospital, Boston; and 5Infinity Pharmaceuticals, Cambridge, Massachusetts Behavioral Neurogenetics Laboratory, Department of Psychological Sciences, Purdue University, West Lafayette, Indiana; and Authors' Affiliations: 1Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; 2Bioinformatics and Computational Genomics Laboratory, Institut de Recherches Cliniques de Montréal, Montreal, Quebec, Canada; 3Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada; 4Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; 5Dana-Farber Cancer Institute, Center for Cancer Systems Biology and Department of Genetics, Harvard Medical School, Boston University School of Medicine and Biomedical Engineering Department, Boston University, Boston, Massachusetts; 6Unité de Génomique du Myélome, Laboratoire UGM, University Hospital, CHU Rangueil, Toulouse, France; 7Hematology Laboratory, University Hospital; and INSERM U892, Nantes, France; 8Molecular Diagnostics Laboratory, Dana Farber Cancer Institute, Boston, Massachusetts; 9Biotique Systems Inc., www.biotiquesystems.com; 10Adult Leukemia Program, Dana Molecular Diagnostics Laboratory, The Dana-Farber Cancer Institute, Boston, MA 02115; Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA Molecular Diagnostics Laboratory, and From the Departments of Pediatric Oncology, Adult Oncology and Cancer Immunology and AIDS, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Children's Hospital, Boston, MA; and the Howard Hughes Medical Institute, Boston, MA. 3Molecular Diagnostics and Department of Computer Science, Virginia Tech, Blacksburg, VA, USA Harvard Medical School, Boston, MA;; Molecular Diagnostics Laboratory, Dana-Farber Cancer Institute, Boston, MA; and From the Departments of Medical Oncology, Pediatric Oncology, and Cancer Biology, Dana-Farber Cancer Institute, Boston; the Department of Medicine, Division of Hematology and Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston; the Departments of Medicine, Pediatrics, Pathology, and Biological Chemistry and Molecular Pharmacology Harvard Medical School, Boston; and the Broad Institute at the Massachusetts Institute of Technology and Harvard, Cambridge, MA. Department of Pediatric Oncology, Dana-Farber Cancer Institute and Department of Pediatrics, Children's Hospital, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA. From the Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Pediatric Oncology, Harvard Medical School, Boston, MA; Clinical Research Institute of Montréal, Montréal, QC, Canada; and Shannon McCormack Advanced Molecular Diagnostics Laboratory, Dana-Farber Cancer Institute, Boston, MA. Dana–Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, MA 02115 |
Incoming Links
Total number of triples: 93.